-transparent.png){kind=logo}
Thirty unmedicated schizophrenics were compared to 29 age-matched controls on auditory and visual event-related brain potential (ERP) paradigms. Twenty-one of these patients were tested again after 1 week on placebo and after 4 weeks on antipsychotic medication. Before treatment, N1, N2, and P3 components of the auditory ERP were smaller in the schizophrenics than in the controls. Although visual N2 was smaller in schizophrenics, visual P3 was not. In spite of significant clinical improvement with antipsychotic treatment, amplitudes of auditory and visual N1, N2, and P3 were not significantly changed. Higher blood levels of antipsychotic medication were related to reductions in auditory P3 latency, however. In addition, higher levels of cerebrospinal fluid (CSF) MHPG (methoxyhydroxyphenylglycol) were associated with larger auditory N1s and larger auditory and visual P3s, suggesting an influence of arousal on these components in schizophrenics. In spite of this influence, reduction of the auditory P3 in schizophrenia is an enduring trait of the disease, which is not affected by antipsychotic medication or clinical improvement.
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
September 2007,
The Psychiatric clinics of North America,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
October 2008,
Archives of general psychiatry,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
June 2015,
British medical bulletin,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
December 2004,
Acta neuropsychiatrica,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
January 1995,
The Israel journal of psychiatry and related sciences,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
June 2011,
The Cochrane database of systematic reviews,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
January 2012,
Schizophrenia bulletin,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
July 2007,
The Cochrane database of systematic reviews,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
September 2007,
Schizophrenia bulletin,
J M Ford, and
P M White, and
J G Csernansky, and
W O Faustman, and
W T Roth, and
A Pfefferbaum
September 2006,
Schizophrenia research,
